Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
AbCellera Biologics Inc. - Common Shares
(NQ:
ABCL
)
3.860
+0.100 (+2.66%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 15, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,986,349
Open
3.770
Bid (Size)
3.840 (1,900)
Ask (Size)
3.850 (1,100)
Prev. Close
3.760
Today's Range
3.770 - 3.900
52wk Range
1.940 - 6.515
Shares Outstanding
287,686,199
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
AbCellera to Report First Quarter 2026 Financial Results on May 11, 2026
April 01, 2026
From
AbCellera Biologics Inc.
Via
Business Wire
CRA: Here’s the TFSA Contribution Room for 2026 and Why Now Is the Best Time to Use It
↗
March 26, 2026
The CRA confirmed $7,000 in TFSA room for 2026. Here's why AbCellera Biologics could be one of the smartest growth stocks to put that money to work in right now.
Via
The Motley Fool
Performance
YTD
+12.5%
+12.5%
1 Month
+8.4%
+8.4%
3 Month
-9.6%
-9.6%
6 Month
-31.3%
-31.3%
1 Year
+58.2%
+58.2%
More News
Read More
AbCellera Biologics Inc (NASDAQ:ABCL) Reports Narrower-Than-Expected Loss on Patent Settlement Windfall
↗
February 24, 2026
Via
Chartmill
Topics
Intellectual Property
These stocks are moving in today's after hours session
↗
February 24, 2026
Via
Chartmill
AbCellera Reports Full Year 2025 Business Results
February 24, 2026
From
AbCellera Biologics Inc.
Via
Business Wire
Earnings Scheduled For November 6, 2025
↗
November 06, 2025
Via
Benzinga
The Biotechnology Renaissance: AI and Capital Collide in a Multi-Trillion Dollar Pivot
February 17, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Initial Public Offering
AbCellera to Present at Upcoming Investor Conferences in March and April 2026
February 11, 2026
From
AbCellera Biologics Inc.
Via
Business Wire
AbCellera to Report Full Year 2025 Financial Results on February 24, 2026
January 22, 2026
From
AbCellera Biologics Inc.
Via
Business Wire
AbCellera Announces First Patients Dosed in Phase 2 Portion of its Phase 1/2 Clinical Trial of ABCL635 for the Treatment of Vasomotor Symptoms Due to Menopause
January 12, 2026
From
AbCellera Biologics Inc.
Via
Business Wire
AbCellera and Bruker Reach Global Settlement of Patent Litigation
December 18, 2025
From
AbCellera Biologics Inc.
Via
Business Wire
AbCellera to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
December 08, 2025
From
AbCellera Biologics Inc.
Via
Business Wire
AbCellera Appoints Dr. Stephen Quake to its Board of Directors
November 10, 2025
From
AbCellera Biologics Inc.
Via
Business Wire
AI Stocks Extend Selloff, Nasdaq 100 Eyes Worst Week Since April: What's Moving Markets Friday?
↗
November 07, 2025
Via
Benzinga
Topics
Artificial Intelligence
AbCellera Biologics Inc (NASDAQ:ABCL) Reports Mixed Q3 2025 Results with Revenue Beat and Wider Loss
↗
November 06, 2025
Via
Chartmill
AbCellera Reports Q3 2025 Business Results
November 06, 2025
From
AbCellera Biologics Inc.
Via
Business Wire
AbCellera to Participate at Upcoming Investor Conferences in November and December 2025
October 07, 2025
From
AbCellera Biologics Inc.
Via
Business Wire
AI Stocks Slide Again, Bitcoin Dips Near $100,000: What's Moving Markets Thursday?
↗
November 06, 2025
Via
Benzinga
Topics
Artificial Intelligence
Stock Market Today: Dow Futures Slip, Nasdaq Rises Amid Mixed Trade—AngioDynamics, Entero Therapeutics, Fermi In Focus
↗
October 02, 2025
Via
Benzinga
Topics
Stocks
Why Did AbCellera's Stock Jump Over 7% After Hours?
↗
October 02, 2025
Via
Benzinga
AbCellera to Report Third Quarter 2025 Financial Results on November 6, 2025
September 29, 2025
From
AbCellera Biologics Inc.
Via
Business Wire
AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer
September 10, 2025
From
AbCellera Biologics Inc.
Via
Business Wire
AbCellera Doses First Participants in a Phase 1 Clinical Trial of ABCL575
August 27, 2025
From
AbCellera Biologics Inc.
Via
Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
↗
August 18, 2025
Via
Benzinga
AbCellera to Participate at Upcoming Investor Conferences in September
August 12, 2025
From
AbCellera Biologics Inc.
Via
Business Wire
Frequently Asked Questions
Is AbCellera Biologics Inc. - Common Shares publicly traded?
Yes, AbCellera Biologics Inc. - Common Shares is publicly traded.
What exchange does AbCellera Biologics Inc. - Common Shares trade on?
AbCellera Biologics Inc. - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for AbCellera Biologics Inc. - Common Shares?
The ticker symbol for AbCellera Biologics Inc. - Common Shares is ABCL on the Nasdaq Stock Market
What is the current price of AbCellera Biologics Inc. - Common Shares?
The current price of AbCellera Biologics Inc. - Common Shares is 3.860
When was AbCellera Biologics Inc. - Common Shares last traded?
The last trade of AbCellera Biologics Inc. - Common Shares was at 04/15/26 04:00 PM ET
What is the market capitalization of AbCellera Biologics Inc. - Common Shares?
The market capitalization of AbCellera Biologics Inc. - Common Shares is 1.11B
How many shares of AbCellera Biologics Inc. - Common Shares are outstanding?
AbCellera Biologics Inc. - Common Shares has 1B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
